| Assay ID | Title | Year | Journal | Article |
|---|
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1625175 | Displacement of [3H]-CP55940 from recombinant human CB2 receptor measured after 2 hrs by liquid scintillation counting method | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID1625170 | Inhibition of [14C]-AEA uptake in human U937 cells preincubated for 15 mins followed by [14C]-AEA addition and measured after 5 mins by scintillation counting method | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID740212 | Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion | 2013 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
| Anti-HBV active constituents from Piper longum. |
| AID453015 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 100 uM after 44 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID362085 | Inhibition of sICAM1/LFA1 interaction-mediated human THP1 cell adhesion at 25 ug/mL after 1 hr by ELISA | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID467873 | Antibacterial activity against Streptococcus minor by agar well diffusion method | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Bioactive constituents of the stem bark of Beilschmiedia zenkeri. |
| AID362088 | Inhibition of sICAM1/LFA1 interaction-mediated human THP1 cell adhesion at 3.13 ug/mL after 1 hr by ELISA | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID362089 | Cytotoxicity against human THP1 cells assessed as cell viability at 3.13 to 25.00 ug/mL by MTT assay | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID1233715 | Larvicidal activity against Aedes aegypti | 2015 | European journal of medicinal chemistry, Jul-15, Volume: 100 | Thiosemicarbazones as Aedes aegypti larvicidal. |
| AID740213 | Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion | 2013 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
| Anti-HBV active constituents from Piper longum. |
| AID316621 | Inhibition of D-galactosamine/TNFalpha-induced cell death in ddY mouse hepatocytes at 30 uM after 20 hrs by MTT assay | 2008 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
| Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-alpha-induced cell death in mouse hepatocytes. |
| AID740215 | Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion | 2013 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
| Anti-HBV active constituents from Piper longum. |
| AID453031 | Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 30 uM by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID453020 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 30 uM after 20 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID362086 | Inhibition of sICAM1/LFA1 interaction-mediated human THP1 cell adhesion at 12.50 ug/mL after 1 hr by ELISA | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID467872 | Antibacterial activity against Bacillus subtilis by agar well diffusion method | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Bioactive constituents of the stem bark of Beilschmiedia zenkeri. |
| AID1625173 | Inhibition of MAGL in human U937 cell homogenates using [3H]-2OG as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins by liquid scintillation counting method | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID362090 | Antiinflammatory activity in mouse | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID453013 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 10 uM after 44 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID362084 | Inhibition of sICAM1/LFA1 interaction-mediated human THP1 cell adhesion after 1 hr by ELISA | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID404405 | Antidiabetic activity in mouse 3T3L1 cells assessed as enhancement of triglyceride accumulation at 10 uM | 2008 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 18, Issue:11
| Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells. |
| AID316619 | Inhibition of D-galactosamine/TNFalpha-induced cell death in ddY mouse hepatocytes at 3 uM after 20 hrs by MTT assay | 2008 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
| Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-alpha-induced cell death in mouse hepatocytes. |
| AID453014 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 30 uM after 44 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID362087 | Inhibition of sICAM1/LFA1 interaction-mediated human THP1 cell adhesion at 6.25 ug/mL after 1 hr by ELISA | 2008 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
| Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. |
| AID740216 | Cytotoxicity against human HepG2(2.2.15) cells | 2013 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
| Anti-HBV active constituents from Piper longum. |
| AID1625176 | Displacement of NBD-Stearate from recombinant human FABP5 measured after 30 mins by fluorescence polarization assay | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID467874 | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 rings after 48 hrs by FACS analysis | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Bioactive constituents of the stem bark of Beilschmiedia zenkeri. |
| AID1625172 | Inhibition of FAAH in human U937 cell homogenates at 100 uM using [14C]-AEA as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins by liquid scintillation counting method relative to control | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID316620 | Inhibition of D-galactosamine/TNFalpha-induced cell death in ddY mouse hepatocytes at 10 uM after 20 hrs by MTT assay | 2008 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
| Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-alpha-induced cell death in mouse hepatocytes. |
| AID404403 | Antidiabetic activity in mouse 3T3L1 cells assessed as enhancement of triglyceride accumulation at 1 uM | 2008 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 18, Issue:11
| Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells. |
| AID404406 | Antidiabetic activity in mouse 3T3L1 cells assessed as enhancement of triglyceride accumulation at 30 uM | 2008 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 18, Issue:11
| Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells. |
| AID453012 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 3 uM after 44 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID453022 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 1 uM after 44 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID404404 | Antidiabetic activity in mouse 3T3L1 cells assessed as enhancement of triglyceride accumulation at 3 uM | 2008 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 18, Issue:11
| Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells. |
| AID453029 | Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 3 uM by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID453030 | Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 10 uM by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID453032 | Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 100 uM by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID467871 | Antibacterial activity against Pseudomonas agarici by agar well diffusion method | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Bioactive constituents of the stem bark of Beilschmiedia zenkeri. |
| AID740214 | Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion | 2013 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
| Anti-HBV active constituents from Piper longum. |
| AID453018 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 3 uM after 20 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| AID1625171 | Inhibition of FAAH in human U937 cell homogenates using [14C]-AEA as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins by liquid scintillation counting method | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID1625174 | Displacement of [3H]-CP55940 from recombinant human CB1 receptor measured after 2 hrs by liquid scintillation counting method | 2019 | Journal of natural products, 03-22, Volume: 82, Issue:3
| Plant-Based Modulators of Endocannabinoid Signaling. |
| AID453019 | Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 10 uM after 20 hrs by MTT assay relative to untreated control | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |